Free Trial
NYSE:MRX

Medicis Pharmaceutical 3/6/2025 Earnings Report

Medicis Pharmaceutical EPS Results

Actual EPS
$0.76
Consensus EPS
$0.64
Beat/Miss
Beat by +$0.12
One Year Ago EPS
N/A

Medicis Pharmaceutical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Medicis Pharmaceutical Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Medicis Pharmaceutical Earnings Headlines

Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
Marex Group plc Announces Launch of a Public Offering
See More Medicis Pharmaceutical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medicis Pharmaceutical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medicis Pharmaceutical and other key companies, straight to your email.

About Medicis Pharmaceutical

Medicis Pharmaceutical (NYSE:MRX)oration (Medicis) together with its wholly owned subsidiaries is an independent specialty pharmaceutical company engaged in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States and Canada. Medicis offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles. Its brands are DYSPORT (abobotulinumtoxinA) 300 Units for Injection, PERLANE Injectable Gel, RESTYLANE Injectable Gel, SOLODYN (minocycline HCl, USP) Extended Release Tablets, VANOS (fluocinonide) Cream 0.1%, ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel and ZYCLARA (imiquimod) Cream 3.75% and 2.5%. As of December 31, 2011, it offered 27 branded products. On December 2, 2011, it acquired Graceway Pharmaceuticals, LLC (Graceway). On November 1, 2011, Medicis sold Medicis Technologies Corporation, formerly LipoSonix, Inc., to Solta Medical, Inc. (Solta).

View Medicis Pharmaceutical Profile

More Earnings Resources from MarketBeat